Luca Vincenzo Cappelli

13PUBLICATIONS
71CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 12, 2026
Comparative Analysis Between the EuroClonality-NGS Approach and the LymphoTrack® Dx Assay for IG/TR Marker Screening in Lymphoid Leukemias: A Campus ALL Study.

|Mar 12, 2026
Very long-term outcomes of chronic-phase chronic myeloid leukaemia patients treated with imatinib: A 25-year real-world cohort study.

Alessandro Costa, Emilia Scalzulli, Ida Carmosino

|Feb 21, 2026
Prognostic impact of treatment-related and geriatric factors in older patients with classic Hodgkin lymphoma: A real-life cohort study.

Silvio Ligia, Giovanni Manfredi Assanto, Tania Soriano

|Jul 02, 2025
BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphoma.

Claudia Pignataro, Pietro Zoppoli, Luca Vincenzo Cappelli

|Jun 13, 2025
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.

Alyssa Bouska, Weiwei Zhang, Sunandini Sharma

|Aug 18, 2022
Endothelial cell-leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities.

Luca Vincenzo Cappelli, Danilo Fiore, Jude M Phillip

Pageof 3

Frequent Collaborators

4 joint publications

Irene Della Starza

4 joint publications

Ilaria Del Giudice

4 joint publications

Giorgio Inghirami

4 joint publications

Danilo Fiore